Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models
Authors:
- Ali TarighatniaATAli Tarighatnia
- Mohammad Reza FouladiMohammad Reza Fouladi
- Mohammad Reza TohidkiaMTMohammad Reza Tohidkia
- Gurkaran JohalGJGurkaran Johal
- Nader D. NaderNNNader D. Nader
- Ayuob AghanejadAAAyuob Aghanejad
- Hossein GhadiriHGHossein Ghadiri
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 66
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Utilization of nanoparticles as X‐ray contrast agents for diagnostic imaging applicationsContrast Media & Molecular Imaging, 2014
- In vitroandin vivoCT imaging using bismuth sulfide modified with a highly biocompatible Pluronic F127Nanotechnology, 2014
- Synthesis and characterization of Bi2S3 composite nanoparticles with high X-ray absorptionMaterials Research Bulletin, 2013
- Dendrimer-stabilized bismuth sulfide nanoparticles: synthesis, characterization, and potential computed tomography imaging applicationsThe Analyst, 2013
- Nanoparticulate X-ray Computed Tomography Contrast Agents: From Design Validation to in Vivo ApplicationsAccounts of Chemical Research, 2012
- Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine ContrastInvestigative Radiology, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- pH-Dependent Synthesis and Stability of Aqueous, Elemental Bismuth Glyconanoparticle Colloids: Potentially Biocompatible X-ray Contrast AgentsChemistry of Materials, 2012
- X‐Ray Computed Tomography Imaging of Breast Cancer by using Targeted Peptide‐Labeled Bismuth Sulfide NanoparticlesAngewandte Chemie International Edition, 2011
- Large‐Scale Synthesis of Bi2S3 Nanodots as a Contrast Agent for In Vivo X‐ray Computed Tomography ImagingAdvanced Materials, 2011